Toronto – Visionary Holdings Inc. (Nasdaq: GV, hereinafter referred to as the “Company”) released its 20-F Annual Report for the fiscal year ended March 31, 2025 on January 12, 2025, fully disclosing the Company’s strategic transformation progress, financial performance, and future development plans. The report shows that the Company has successfully transformed from traditional education and real estate businesses into a diversified enterprise with large health and elderly care, and high-end medical aesthetics as the core, and artificial intelligence (AI) education as a supplement. Emerging businesses have achieved revenue contribution for the first time, laying a solid foundation for future steady growth.
Strategic Transformation Takes Root, Emerging Businesses Initially Become Growth Drivers
Facing external challenges such as Canada’s economic restructuring, tightened education policies, and a downturn in the real estate industry, the Company launched its strategic transformation through a board resolution in September 2023, and completed the layout of core businesses in May 2024. During the reporting period, the life sciences business (including large health and elderly care, anti-aging, and high-end medical aesthetics) achieved revenue of $1.063 million, accounting for 21.1% of total revenue, initially forming a new growth pillar for the Company.
In the field of large health and elderly care, the Company focuses on the intestinal flora maintenance track, launching four patented product series including “Helicobacter Pylori Resistance” and “Intestinal Tract Maintenance”. Through the “platform + maker + store” model, it has deployed sales terminals in the Asian market, practicing the health concept of “nourishment instead of treatment” to provide precise maintenance solutions for people with gastrointestinal sub-health and chronic diseases. Over the next three years, the Company plans to fully promote brand franchise stores based on the existing market foundation, helping 10 million users develop scientific gastrointestinal maintenance habits, with the goal of striving to achieve annual revenue of over $100 million (this target is based on current market demand expectations and channel expansion plans, and actual achievement is subject to factors such as market competition and the pace of franchise promotion).
In the anti-aging and high-end medical aesthetics business, the Company integrates North American medical technology with traditional health preservation concepts, building a multi-dimensional service system covering international cutting-edge physical examination centers, cell anti-aging centers, and chronic disease management. The Company plans to build an international high-end anti-aging and medical aesthetics health care center in Toronto, with an expected annual revenue of over CAD 10 million after the project is launched (specifically depending on the progress of property renovation and market expansion results). During the reporting period, the Company has established strategic cooperation with industry leaders such as Jiangsu Yike Regenerative Medicine Technology Co., Ltd. and Anhui WeiKang KangLing Medical Technology Co., Ltd., obtaining industry-leading patented technologies and product support to accelerate the construction of a global high-end medical aesthetics service network.
The AI education business continues to operate steadily, providing Ontario Secondary School Diploma (OSSD), vocational education, and master’s-doctorate bridging programs through an online-offline integrated model. Cooperating with multiple Canadian public institutions, it offers one-stop services for global students including visa processing, accommodation arrangements, and employment guidance. Relying on its mature teaching system and industry reputation, it maintains market competitiveness with relatively stable revenue scale.
Financial Performance Reflects Transformation Pains, Core Operational Indicators Steadily Improve
In fiscal 2025, the Company’s total revenue was $5.044 million, a year-on-year decrease of 46.2% due to the contraction of the real estate leasing business and changes in education industry policies. Among them, rental income was $2.797 million, tuition income was $1.184 million, and product sales revenue from the life sciences business was $1.063 million, with the revenue proportion of emerging businesses gradually increasing.
In terms of profitability, the Company recorded a net loss of $15.746 million during the period, mainly affected by one-time investments during the transformation period, property impairment of $4.696 million, and financing costs, which is a phased phenomenon in the process of strategic transformation. At the core operational efficiency level, the gross profit margin increased by 0.9 percentage points year-on-year to 28.0%, among which the gross profit margin of the education service segment rose to 64.4%, indicating continuous optimization of the profitability of core businesses; in terms of cash flow, the Company achieved a net cash inflow of $14.51 million from investing activities through property disposal, effectively supporting the capital needs during the transformation period; the net cash outflow from operating activities was $2.968 million, narrowing from $4.104 million in the previous year, reflecting steady improvement in operating capital management efficiency.
As of March 31, 2025, the Company’s total assets were $63.627 million, including net fixed assets of $57.576 million and net intangible assets of $0.849 million. In response to issues such as certain bank loan defaults and negative working capital of $54.5 million, the Company has launched a number of response measures: including advancing equity financing, negotiating debt restructuring and extension with creditors, and some creditors have agreed to temporary extension arrangements.
Multi-Dimensional Layout for the Future, Pragmatically Promoting High-Quality Development
The report clarifies three pragmatic development directions for the Company’s future: first, continue to deepen the large health and high-end medical aesthetics track, integrate global technology, market and team resources based on existing strategic cooperation foundations, and accelerate expansion through prudent mergers and acquisitions, aiming to achieve annual revenue of over $100 million in this segment within 2 years (based on the current pace of cooperation implementation and market expansion plans); second, upgrade the AI education ecosystem, gradually build an AI student management system and VR-based virtual teaching laboratory, expand cooperation with more international institutions, steadily expand the marketing network in core markets such as Asia, focusing on deepening the existing market and steadily penetrating the incremental market; third, improve corporate governance and internal controls, launch optimization plans for existing internal control deficiencies, including recruiting professional financial and compliance talents, strengthening comprehensive compliance training, and standardizing the operation of the audit committee, to continuously improve the quality of financial reporting and operational management efficiency.
In addition, the Company has recently signed a number of strategic cooperation agreements, including cooperating with Alto Plus Ltd. to promote the application of AI in the education field, further enriching the connotation of the AI education business. These strategic layouts will continuously strengthen the Company’s core competitiveness, helping the Company achieve steady development in the two high-growth tracks of life sciences and AI education.
Xiyong Hou, CEO of Visionary Holdings Inc., said: “Fiscal 2025 is a crucial implementation year for the Company’s strategic transformation. The revenue breakthrough of emerging businesses has verified the feasibility of our strategic direction. In the future, the Company will focus on high-potential tracks, deepen global cooperation at a pragmatic pace, drive sustainable growth through technological innovation and high-quality services, and create long-term value for shareholders.”
About Visionary Holdings Inc.
Visionary Holdings Inc. is a diversified holding company registered in Ontario, Canada, listed on Nasdaq (ticker symbol: GV). The Company’s core businesses cover three major segments: large health and elderly care, anti-aging and high-end medical aesthetics, and AI education. It is committed to providing high-quality health services and educational resources to global customers, building a sustainable and growing technology-driven sunrise industry ecosystem.
Cautionary Note Regarding Forward-Looking Statements
This press release contains “forward-looking statements” as defined under the Securities Exchange Act of 1934. These statements relate to the Company’s future business development, revenue targets, strategic layouts, and other matters. Such statements are made based on the current market environment, industry trends, and the Company’s plans, and are subject to various known and unknown risks, including but not limited to: intensified industry competition, changes in relevant policies, slower-than-expected financing progress, fluctuations in market demand, and slower-than-expected progress in cooperation implementation. Actual results may differ materially from the forward-looking statements. Investors should carefully read the risk factors section in the Company’s 20-F Annual Report and rationally assess investment value in combination with the Company’s actual operating conditions.
Contact: Xiyong Hou
Telephone: +1 905-305-1881
Email: [email protected]
Company Website: http://www.visionary.holdings
Comments (0)